Back to Search Start Over

HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.

Authors :
Quan, Lina
Jia, Chuiming
Guo, Yiwei
Chen, Yao
Wang, Xinya
Xu, Qiuting
Zhang, Yu
Source :
Journal of Translational Medicine. 11/18/2022, Vol. 20 Issue 1, p1-12. 12p.
Publication Year :
2022

Abstract

<bold>Background: </bold>Multiple myeloma (MM) is a malignancy of plasma cells that remains incurable. Toll-like receptor 4 (TLR4) acts as a stress-responsive signal, protecting mitochondria during proteasome inhibitor (PI) exposure, maintaining mitochondrial metabolism and increasing drug resistance in MM. However, the mechanism of TLR4 regulation remains elusive.<bold>Aims: </bold>The purpose of this study was to investigate the methylation pattern of multiple myeloma and its effect on the expression of HNRNPA2B1 and downstream targets.<bold>Methods: </bold>The methylation level in MM and normal bone marrow specimens was detected using a colorimetric assay. HNRNPA2B1 gene knockdown was achieved in RPMI 8226 MM cells via adenovirus transfection. CCK8 and flow cytometric assays were used to detect proliferation and apoptosis, respectively. Transcriptome sequencing and m6A methylation MeRIP sequencing were applied, and differentially expressed genes (DEGs) were detected. Three independent NCBI GEO datasets were applied to examine the effects of HNRNPA2B1 and TLR4 expression on MM patient survival.<bold>Results: </bold>HNRNPA2B1 promoted MM progression. Clinical data from database revealed that HNRNPA2B1 was adverse prognostic factor for survival among MM patients. Furthermore, transcriptome sequencing and methylation sequencing showed that HNRNPA2B1 recognized and was enriched at the m6A sites of TLR4 and TLR4 was down-regulated of both the m6A level and transcription level in HNRNPA2B1-knockdown MM cells. Moreover, TLR4 was an adverse survival prognostic factor based on database analysis.<bold>Conclusion: </bold>Overall, our study implies that the RNA-binding protein HNRNPA2B1 increases cell proliferation and deregulates cell apoptosis in MM through TLR4 signaling. Our study suggests HNRNPA2B1 as a potential therapeutic target for MM. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14795876
Volume :
20
Issue :
1
Database :
Academic Search Index
Journal :
Journal of Translational Medicine
Publication Type :
Academic Journal
Accession number :
160307350
Full Text :
https://doi.org/10.1186/s12967-022-03750-8